These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 10411093

  • 1. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
    Ropiquet F, Giri D, Lamb DJ, Ittmann M.
    J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
    [Abstract] [Full Text] [Related]

  • 2. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
    Giri D, Ropiquet F, Ittmann M.
    J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
    [Abstract] [Full Text] [Related]

  • 3. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N, Kwabi-Addo B, Wang J, Ittmann M.
    Prostate; 2004 Jun 15; 60(1):18-24. PubMed ID: 15129425
    [Abstract] [Full Text] [Related]

  • 4. Cellular senescence in the pathogenesis of benign prostatic hyperplasia.
    Castro P, Giri D, Lamb D, Ittmann M.
    Prostate; 2003 Apr 01; 55(1):30-8. PubMed ID: 12640658
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.
    Giri D, Ittmann M.
    Am J Pathol; 2000 Jul 01; 157(1):249-55. PubMed ID: 10880394
    [Abstract] [Full Text] [Related]

  • 6. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W, Zhang X, Mize GJ, Takayama TK.
    Prostate; 2008 Jul 01; 68(10):1064-75. PubMed ID: 18386288
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.
    Castro P, Xia C, Gomez L, Lamb DJ, Ittmann M.
    Prostate; 2004 Jul 01; 60(2):153-9. PubMed ID: 15162381
    [Abstract] [Full Text] [Related]

  • 8. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D, Ropiquet F, Ittmann M.
    Clin Cancer Res; 1999 May 01; 5(5):1063-71. PubMed ID: 10353739
    [Abstract] [Full Text] [Related]

  • 9. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N, Karyotis I, Delakas D, Spandidos DA.
    Int J Oncol; 2006 Aug 01; 29(2):305-14. PubMed ID: 16820871
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q, Shi J, Chen L, Wang CY, Park I, Lee C, Zhang J.
    BJU Int; 2008 Feb 01; 101(4):497-502. PubMed ID: 18190643
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N, Würdinger R, Zippel A, Aumüller G, Wennemuth G.
    Prostate; 2010 Sep 01; 70(12):1350-8. PubMed ID: 20623639
    [Abstract] [Full Text] [Related]

  • 15. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar 01; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
    Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M.
    Prostate; 2002 Jun 01; 52(1):43-58. PubMed ID: 11992619
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P, Royuela, Bethencourt R, Ruiz A, Fraile B, Paniagua R.
    Cytokine; 1999 Sep 01; 11(9):722-7. PubMed ID: 10479409
    [Abstract] [Full Text] [Related]

  • 18. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK, Nanda J, Chapman KE, Habib FK.
    J Endocrinol; 2008 Jun 01; 197(3):483-91. PubMed ID: 18492814
    [Abstract] [Full Text] [Related]

  • 19. [Role of bFGF and TGF-beta1 in primary cultured prostatic stromal cells].
    Gu H, Dong ZX, Wang CB, Yuan YF, Hou JH.
    Zhonghua Nan Ke Xue; 2006 Oct 01; 12(10):917-22. PubMed ID: 17121024
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury.
    Tanaka T, Saika S, Ohnishi Y, Ooshima A, McAvoy JW, Liu CY, Azhar M, Doetschman T, Kao WW.
    Mol Vis; 2004 Jul 15; 10():462-7. PubMed ID: 15273655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.